These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16465189)

  • 41. [A case-control study of prostate cancer].
    Du SF; Shi LY; He SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Dec; 17(6):343-5. PubMed ID: 9387599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.
    Möller E; Adami HO; Mucci LA; Lundholm C; Bellocco R; Johansson JE; Grönberg H; Bälter K
    Cancer Causes Control; 2013 Dec; 24(12):2143-55. PubMed ID: 24048969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study.
    Kakizaki M; Inoue K; Kuriyama S; Sone T; Matsuda-Ohmori K; Nakaya N; Fukudo S; Tsuji I;
    Br J Cancer; 2008 Jul; 99(1):176-8. PubMed ID: 18542076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.
    Zmuda JM; Modugno F; Weissfeld JL; Cauley JA; Trump DL; Moffett SP; Ferrell RE
    Oncology; 2006; 70(3):185-9. PubMed ID: 16763406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort.
    Habel LA; Van Den Eeden SK; Friedman GD
    Prostate; 2000 May; 43(2):136-43. PubMed ID: 10754529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body mass index and subsequent risk of kidney cancer: a prospective cohort study in Japan.
    Sawada N; Inoue M; Sasazuki S; Iwasaki M; Yamaji T; Shimazu T; Tsugane S;
    Ann Epidemiol; 2010 Jun; 20(6):466-72. PubMed ID: 20470974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The geography of prostate cancer and its treatment in Japan.
    Oishi K; Yoshida O; Schroeder FH
    Cancer Surv; 1995; 23():267-80. PubMed ID: 7621463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins.
    Lundqvist E; Kaprio J; Verkasalo PK; Pukkala E; Koskenvuo M; Söderberg KC; Feychting M
    Int J Cancer; 2007 Aug; 121(4):810-8. PubMed ID: 17455257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.
    Holick CN; Giovannucci EL; Stampfer MJ; Michaud DS
    Int J Cancer; 2007 Jan; 120(1):140-6. PubMed ID: 17036323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years.
    Lund Håheim L; Wisløff TF; Holme I; Nafstad P
    Am J Epidemiol; 2006 Oct; 164(8):769-74. PubMed ID: 16952929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for prostate cancer: A national case-control study.
    Cox B; Sneyd MJ; Paul C; Skegg DC
    Int J Cancer; 2006 Oct; 119(7):1690-4. PubMed ID: 16646073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validity of self-reported height and weight in a Japanese workplace population.
    Wada K; Tamakoshi K; Tsunekawa T; Otsuka R; Zhang H; Murata C; Nagasawa N; Matsushita K; Sugiura K; Yatsuya H; Toyoshima H
    Int J Obes (Lond); 2005 Sep; 29(9):1093-9. PubMed ID: 15925952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of prostate cancer in older Japanese asthmatics.
    Ohrui T; Yamaya M; Sato T; Matsui T; Sasaki H; Namima T
    J Am Geriatr Soc; 2002 Jan; 50(1):202. PubMed ID: 12028273
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostate cancer and body size at different ages: an Italian multicentre case-control study.
    Dal Maso L; Zucchetto A; La Vecchia C; Montella M; Conti E; Canzonieri V; Talamini R; Tavani A; Negri E; Garbeglio A; Franceschi S
    Br J Cancer; 2004 Jun; 90(11):2176-80. PubMed ID: 15150581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organochlorines and prostate cancer in Japan: no link in men without occupational exposures.
    Freeman KS
    Environ Health Perspect; 2010 May; 118(5):A216. PubMed ID: 20435550
    [No Abstract]   [Full Text] [Related]  

  • 60. Case-control study of prostate cancer in black patients in Soweto, South Africa.
    Walker AR; Walker BF; Tsotetsi NG; Sebitso C; Siwedi D; Walker AJ
    Br J Cancer; 1992 Mar; 65(3):438-41. PubMed ID: 1558801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.